SCHEMBL29619399

SCHEMBL29619399

Cc1c(C2CCN(C(=O)OC(C)(C)C)CC2)[nH]c2nnc(-c3ccccc3O)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 2/20 0.53
▸ SMARCA4 P51532 2/20 0.53
▸ PBRM1 Q86U86 2/20 0.53
▸ HPGDS O60760 1/20 0.42
▸ CNR1 P21554 1/20 0.42
▸ THRB P10828 2/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CCNK O75909 1/20 0.41
▸ CDK12 Q9NYV4 1/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ JAK1 P23458 1/20 0.41
▸ TYK2 P29597 1/20 0.41
▸ JAK3 P52333 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ NAMPT P43490 1/20 0.41
▸ GPR119 Q8TDV5 4/20 0.40
▸ GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24461526 1.00 SMARCA2 (0.53) SMARCA2SMARCA4PBRM1HPGDSCNR1
SCHEMBL29619410 0.87 SMARCA2 (0.53) SMARCA2SMARCA4PBRM1HPGDSCNR1
SCHEMBL24461790 0.87 SMARCA2 (0.53) SMARCA2SMARCA4PBRM1HPGDSCNR1
SCHEMBL29072012 0.87 PBRM1 (0.37) SMARCA2SMARCA4PBRM1SMN1; SMN2
SCHEMBL23581053 0.83 SMARCA2 (0.51) SMARCA2SMARCA4PBRM1HPGDSTHRB
SCHEMBL22777626 0.83 SMARCA2 (0.54) SMARCA2SMARCA4PBRM1HPGDSTHRB
SCHEMBL24461631 0.82 CNR1 (0.48) HPGDSCNR1THRBKDM4EMAPT
SCHEMBL29619438 0.82 CNR1 (0.48) HPGDSCNR1THRBKDM4EMAPT
SCHEMBL29619449 0.81 SMARCA2 (0.49) SMARCA2SMARCA4PBRM1HPGDSKDM4E
SCHEMBL29072084 0.81 SMARCA2 (0.49) SMARCA2SMARCA4PBRM1HPGDSKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022109426-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2022-05-27 — — WO disclosed
Send feedback